Fulcrum Therapeutics Grants 55,500 Stock Options to New Employees

Fulcrum Therapeutics, Inc. granted 55,500 non-statutory stock options to two new employees as an inducement to employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $7.02 per share, matching the closing price on the May 4, 2026 grant date. These options vest over four years, with 25% vesting on the first anniversary and the remainder in equal quarterly installments over the subsequent three years, subject to continued service.